Use of Immunomodulatory Biomaterials in Diabetes Therapy

Abstract

Type 1 diabetes is a complex and chronic autoimmune disease that affects millions of individuals worldwide. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2024.